Inflammation And Salt-Inducible Kinases - A Potential Novel Therapeutic Strategy In Patients With Heart Failure

Medicine & Life Sciences

1. Metformin 100%
2. Clinical Studies 75%
3. Heart Failure 68%
4. Cardiovascular Diseases 67%
5. Inflammation 54%
6. Type 2 Diabetes Mellitus 23%
7. Sodium-Glucose Transporter 2 Inhibitors 22%
8. Symporters 21%
9. Glucagon-Like Peptide-1 Receptor 20%
10. Therapeutics 15%
11. Anti-Inflammatory Agents 11%
12. Randomized Controlled Trials 10%
13. Guidelines 9%